The Max Planck Institute of Biochemistry is participating in the start-up phase of the German Center for Child and Adolescent Health (DZKJ).
Johannes Müller-Reif, project group leader in Matthias Mann's department, will lead DZKJ projects as an expert in proteome analysis.
The German Center for Child and Adolescent Health (DZKJ) will become a new partner of the German Centers for Health Research (DZG) from June 1, 2024. The nationally organized and networked research center will receive 30 million euros in funding from the Federal Ministry of Education and Research during the two-year start-up phase. The DZKJ office will be located at the University Medical Center Göttingen (UMG).
In Munich, scientists and physicians from the Max Planck Institute of Biochemistry, Ludwig-Maximilians-Universität, LMU Klinikum, Technical University of Munich (TUM), University Hospital rechts der Isar of the TUM and Helmholtz Munich have founded the Munich Child Health Alliance. This alliance is dedicated to issues of child and adolescent health within the framework of the DZKJ.
At the Max Planck Institute of Biochemistry, Johannes Müller-Reif, project group leader in Matthias Mann's department, will lead the DZKJ projects as an expert in proteome analysis. "I am looking forward to the challenge of deciphering pediatric diseases at the molecular level and contributing to new medical applications," says Müller-Reif. The establishment of the DZKJ is a significant step towards improving health research and care for children and adolescents in Germany.
